Verified through rigorous HPLC and LC-MS/MS testing under strict ISO/cGMP standards, catering directly to international procurement specifications.




Bridging traditional Asian pharmacopoeia with next-generation green chromatography and bio-fermentation networks across the Gyeonggi-Seoul bio-corridor.
The Seoul metropolitan region, anchored by dynamic research corridors in Gangnam, Magok Industrial Complex, and Pangyo Techno Valley, represents the epicenter of botanical R&D in East Asia. As an international plant extract manufacturer and exporter centered in Seoul, our operational architecture synthesizes upstream scientific precision with streamlined maritime and air transit out of Incheon International Logistics Port.
Our extraction centers incorporate automated Supercritical Fluid CO2 (SFE) extraction and continuous resin-column chromatography, maintaining zero residual solvents while preserving thermal-sensitive polyphenols, polysaccharides, and saponins.
The Ministry of Food and Drug Safety (MFDS) enforces some of the world's most rigorous botanical identity standards. Operating from Seoul necessitates compliance with monographed limits for heavy metals (Lead, Arsenic, Cadmium, Mercury via ICP-MS), residual pesticide screens exceeding 400 compounds, and polycyclic aromatic hydrocarbons (PAHs).
Our analytical suites align directly with both local MFDS protocols and global compendia (USP, Ph. Eur., and FCC), delivering full cross-continental regulatory safety with every batch exported.
Capitalizing on Korea’s historical prowess in bioconversion, our Seoul facilities utilize microbiological fermentation to elevate natural bioavailability. From converting soy isoflavones into bioactive equol, to fermenting Bacillus subtilis natto for menaquinone-7 (Vitamin K2 MK-7), our bio-catalytic processing achieves higher isomeric purity and metabolic efficacy compared to conventional synthetic alternatives.
Addressing the shifting landscape of regulatory stringency, supply chain fragmentation, and clinical validation across multinational pharmaceutical, dietary, and cosmetic sectors.
Global pharmaceutical and nutraceutical conglomerates frequently encounter lot-to-lot bioactivity variations when procuring unstandardized botanical biomass. Seasonal crop differences, geographical chemical variance, and inadequate drying techniques inevitably result in erratic clinical outcomes.
Our Seoul-based manufacturing framework integrates comprehensive fingerprinted profiling—utilizing high-resolution High-Performance Liquid Chromatography (HPLC) coupled with Fourier Transform Infrared Spectroscopy (FTIR). By establishing validated Marker Compound Quantification, we guarantee that every kilogram shipped delivers consistent active components, ensuring precise dosing in final formulations.
With Seoul recognized as the premier global incubator for clean-label skincare, cosmetic R&D divisions demand clean, highly skin-permeable bio-actives. Traditional solvent-extracted herbs carry allergens, heavy odors, and pigments that jeopardize formula stability.
We deploy continuous molecular distillation, membrane filtration, and microencapsulation. These processing innovations isolate targeted polyphenols (such as Ellagic Acid and Dihydromyricetin) without thermal degradation, achieving exceptional clarity, high solubility in water-phase emulsions, and optimized transdermal bioavailability.
Pioneering the paradigm shift from basic solvent extraction toward synthetic biology, continuous enzymatic biotransformation, and AI-optimized chromatographic purification.
Total phase-out of Class II toxic organic solvents across all production lines. Implementation of tunable subcritical water extraction systems operating under elevated pressures to hydrolyze and extract target bioflavonoids without thermal degradation.
Deployment of immobilized enzyme reactors (Lactase, Glucosidase, Protease) engineered to cleave glycosidic bonds in natural saponins and polyphenols, yielding smaller, aglycone molecules that display multi-fold improvements in human metabolic absorption.
Integration of pharmaceutical-grade liposomal encapsulation and cyclodextrin-inclusion complexes in our Seoul pilot plants. Ensuring vulnerable molecules like Curcumin, MK-7, and PQQ resist gastric degradation and achieve systemic delivery.
Ensuring complete regulatory synchronicity across US-FDA 21 CFR Part 111, EU Novel Food guidelines, and APAC botanical monographs.
Every commercial consignment exported from Seoul is accompanied by extensive technical documentation: detailed Certificates of Analysis (COA) specifying exact analytical test methods, Material Safety Data Sheets (MSDS), TSE/BSE risk-free declarations, and confirmed non-GMO certifications.
Our quality management operations are independently verified against ISO 9001:2015, ISO 22000, and cGMP standards. We maintain routine surveillance by international bodies including SGS, Eurofins, and MFDS-certified third-party laboratories to guarantee uncompromised purity and reliability.
With immediate access to Incheon's international air logistics corridor, we support rapid air shipment of temperature-sensitive enzymes and liposomal actives with validated cold-chain packaging (2–8°C), while handling dry bulk FCL/LCL ocean shipments via Busan Port for maximum cost efficiency.
Extensively exported from our supply infrastructure to formulation labs across North America, Europe, East Asia, and the Middle East.







Detailed technical, quality, and regulatory insights addressing the fundamental concerns of import managers and formulation chemists.
Accelerate your product development cycles with analytically validated, regulatory-compliant botanical extracts, enzymes, and active pharmaceutical intermediates.
Send Inquiry Now